| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 6.377 | 7.608 | 3.883 | 8.573 | 35.727 | 32.241 | 50.176 | 26.526 | 29.091 | 38.085 |
| Total Income - EUR | 6.377 | 7.805 | 3.933 | 8.573 | 35.727 | 35.991 | 50.246 | 26.784 | 29.091 | 38.088 |
| Total Expenses - EUR | 7.253 | 8.747 | 10.617 | 8.385 | 18.701 | 18.034 | 23.651 | 24.838 | 27.849 | 21.259 |
| Gross Profit/Loss - EUR | -876 | -942 | -6.684 | 188 | 17.026 | 17.957 | 26.595 | 1.946 | 1.242 | 16.830 |
| Net Profit/Loss - EUR | -1.067 | -1.176 | -6.802 | -63 | 15.954 | 17.018 | 25.414 | 1.316 | 951 | 16.449 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Biomedical Remed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 10.267 | 5.961 | 0 | 0 | 15.101 | 38.739 | 30.285 | 21.238 | 16.022 | 16.737 |
| Current Assets | 21.147 | 23.657 | 22.066 | 22.629 | 1.889 | 9.349 | 26.246 | 2.636 | 5.273 | 17.178 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 558 | 4.150 |
| Receivables | 718 | 570 | 1 | 172 | 794 | 1.447 | 2.780 | 1.540 | 2.549 | 5.203 |
| Cash | 20.428 | 23.087 | 22.066 | 22.458 | 1.094 | 7.902 | 23.466 | 1.096 | 2.166 | 7.825 |
| Shareholders Funds | 30.279 | 28.794 | 21.505 | 21.047 | -9.641 | 7.560 | 32.806 | -224 | 728 | 17.172 |
| Social Capital | 49.539 | 49.034 | 48.204 | 47.319 | 169 | 165 | 162 | 162 | 162 | 161 |
| Debts | 1.368 | 1.102 | 842 | 1.883 | 26.943 | 40.662 | 23.804 | 24.259 | 20.822 | 16.996 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Biomedical Remed Srl